HK Stock MarketDetailed Quotes

KAISA HEALTH (00876)

Watchlist
  • 0.109
  • +0.003+2.83%
Market Closed Apr 30 14:06 CST
549.59MMarket Cap-12.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KAISA HEALTH (00876) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
-24.95%139.11M
-21.40%69.58M
-0.28%185.36M
-4.40%88.52M
-2.93%185.88M
-1.48%92.59M
-8.65%191.5M
-9.00%93.98M
14.04%209.63M
35.58%103.28M
Operating income
-24.95%139.11M
-21.40%69.58M
-0.28%185.36M
-4.40%88.52M
-2.93%185.88M
-1.48%92.59M
-8.65%191.5M
-9.00%93.98M
14.04%209.63M
35.58%103.28M
Cost of sales
14.52%-88.47M
12.40%-44.38M
1.25%-103.5M
6.23%-50.66M
3.79%-104.81M
0.03%-54.03M
2.92%-108.93M
-9.81%-54.05M
-19.57%-112.21M
-25.36%-49.22M
Operating expenses
14.52%-88.47M
12.40%-44.38M
1.25%-103.5M
6.23%-50.66M
3.79%-104.81M
0.03%-54.03M
2.92%-108.93M
-9.81%-54.05M
-19.57%-112.21M
-25.36%-49.22M
Gross profit
-38.13%50.64M
-33.44%25.19M
0.97%81.86M
-1.84%37.85M
-1.81%81.07M
-3.44%38.56M
-15.24%82.57M
-26.13%39.93M
8.28%97.42M
46.44%54.06M
Selling expenses
-7.46%-51.18M
9.03%-21.76M
3.71%-47.63M
-0.43%-23.92M
-7.30%-49.47M
-18.72%-23.82M
6.20%-46.1M
1.57%-20.06M
-51.99%-49.14M
-59.65%-20.38M
Administrative expenses
23.66%-35.09M
24.97%-14.73M
20.67%-45.96M
22.56%-19.63M
32.98%-57.93M
46.71%-25.35M
20.08%-86.45M
-8.01%-47.57M
-36.73%-108.16M
-14.45%-44.04M
Research and development expenses
-35.54%-16.91M
9.38%-7.78M
25.89%-12.48M
---8.58M
---16.84M
----
----
----
----
----
Profit from asset sales
----
----
----
----
--69.39M
--67.86M
----
----
----
----
Revaluation surplus
208.08%10.56M
174.65%8.98M
52.14%-9.77M
56.15%-12.03M
29.94%-20.42M
23.03%-27.43M
-150.48%-29.15M
-171.45%-35.64M
112.33%57.73M
316.26%49.88M
-Changes in the fair value of financial assets
208.08%10.56M
174.65%8.98M
52.14%-9.77M
56.15%-12.03M
-69.18%-20.42M
23.03%-27.43M
-121.12%-12.07M
-174.86%-35.64M
152.08%57.15M
372.03%47.61M
-Changes in the fair value of other assets
----
----
----
----
----
----
-3,009.03%-17.08M
----
-87.01%587K
19.86%2.28M
Impairment and provision
68.75%-5.96M
-87.12%197K
-571.23%-19.08M
436.49%1.53M
96.24%-2.84M
100.58%285K
-392.06%-75.64M
-297.28%-49.55M
177.32%25.9M
3,239.50%25.12M
-Impairment of property, machinery and equipment
----
----
----
----
----
----
---64.13M
---41.42M
----
----
-Other impairment is provision
68.75%-5.96M
-87.12%197K
-571.23%-19.08M
436.49%1.53M
75.30%-2.84M
103.51%285K
-144.44%-11.51M
-132.36%-8.13M
177.32%25.9M
3,239.50%25.12M
Special items of operating profit
-69.33%1.58M
-69.19%792K
-23.50%5.16M
-80.15%2.57M
179.67%6.75M
474.15%12.95M
-94.36%-8.47M
40.57%-3.46M
65.43%-4.36M
-10.43%-5.83M
Operating profit
3.23%-46.35M
59.00%-9.11M
-593.02%-47.9M
-151.58%-22.21M
105.95%9.72M
137.01%43.06M
-942.00%-163.23M
-297.84%-116.35M
148.00%19.39M
798.21%58.81M
Financing cost
24.01%-592K
44.25%-228K
78.77%-779K
86.47%-409K
52.53%-3.67M
26.00%-3.02M
5.51%-7.73M
-610.26%-4.08M
-652.81%-8.18M
-103.18%-575K
Earning before tax
3.57%-46.95M
58.74%-9.33M
-905.18%-48.68M
-156.50%-22.62M
103.54%6.05M
133.25%40.04M
-1,626.05%-170.96M
-306.80%-120.43M
127.01%11.2M
996.75%58.24M
Tax
105.05%97K
102.98%49K
-1,945.19%-1.92M
-30.27%-1.64M
108.90%104K
-534.17%-1.26M
95.03%-1.17M
-332.61%-199K
-3,123.91%-23.53M
-127.88%-46K
After-tax profit from continuing operations
7.42%-46.85M
61.73%-9.29M
-922.76%-50.6M
-162.57%-24.26M
103.57%6.15M
132.14%38.78M
-1,296.84%-172.13M
-307.31%-120.63M
69.72%-12.32M
1,019.40%58.19M
Earning after tax
7.42%-46.85M
61.73%-9.29M
-922.76%-50.6M
-162.57%-24.26M
103.57%6.15M
132.14%38.78M
-1,296.84%-172.13M
-307.31%-120.63M
69.72%-12.32M
1,019.40%58.19M
Minority profit
96.00%-170K
---160K
-222.08%-4.25M
----
97.30%-1.32M
94.81%-1.23M
-232.48%-48.81M
-853.33%-23.61M
-1,363.81%-14.68M
-797.46%-2.48M
Profit attributable to shareholders
-0.70%-46.68M
62.39%-9.13M
-720.72%-46.36M
-160.66%-24.26M
106.06%7.47M
141.23%40M
-5,327.55%-123.32M
-259.92%-97.02M
105.94%2.36M
1,102.25%60.67M
Basic earnings per share
-1.09%-0.0093
62.50%-0.0018
-713.33%-0.0092
-160.76%-0.0048
106.12%0.0015
141.15%0.0079
-5,000.00%-0.0245
-260.00%-0.0192
106.33%0.0005
1,100.00%0.012
Diluted earnings per share
-1.09%-0.0093
62.50%-0.0018
-713.33%-0.0092
-160.76%-0.0048
106.12%0.0015
141.15%0.0079
-5,000.00%-0.0245
-260.00%-0.0192
106.33%0.0005
1,100.00%0.012
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
--
Zhongshen Zhonghuan (Hong Kong) Fuxin Certified Public Accountants Limited
--
Kaiyuan Xinde Certified Public Accountants Co., Ltd.
--
Kaiyuan Xinde Certified Public Accountants Co., Ltd.
--
Grant Thornton (Hong Kong) Limited
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover -24.95%139.11M-21.40%69.58M-0.28%185.36M-4.40%88.52M-2.93%185.88M-1.48%92.59M-8.65%191.5M-9.00%93.98M14.04%209.63M35.58%103.28M
Operating income -24.95%139.11M-21.40%69.58M-0.28%185.36M-4.40%88.52M-2.93%185.88M-1.48%92.59M-8.65%191.5M-9.00%93.98M14.04%209.63M35.58%103.28M
Cost of sales 14.52%-88.47M12.40%-44.38M1.25%-103.5M6.23%-50.66M3.79%-104.81M0.03%-54.03M2.92%-108.93M-9.81%-54.05M-19.57%-112.21M-25.36%-49.22M
Operating expenses 14.52%-88.47M12.40%-44.38M1.25%-103.5M6.23%-50.66M3.79%-104.81M0.03%-54.03M2.92%-108.93M-9.81%-54.05M-19.57%-112.21M-25.36%-49.22M
Gross profit -38.13%50.64M-33.44%25.19M0.97%81.86M-1.84%37.85M-1.81%81.07M-3.44%38.56M-15.24%82.57M-26.13%39.93M8.28%97.42M46.44%54.06M
Selling expenses -7.46%-51.18M9.03%-21.76M3.71%-47.63M-0.43%-23.92M-7.30%-49.47M-18.72%-23.82M6.20%-46.1M1.57%-20.06M-51.99%-49.14M-59.65%-20.38M
Administrative expenses 23.66%-35.09M24.97%-14.73M20.67%-45.96M22.56%-19.63M32.98%-57.93M46.71%-25.35M20.08%-86.45M-8.01%-47.57M-36.73%-108.16M-14.45%-44.04M
Research and development expenses -35.54%-16.91M9.38%-7.78M25.89%-12.48M---8.58M---16.84M--------------------
Profit from asset sales ------------------69.39M--67.86M----------------
Revaluation surplus 208.08%10.56M174.65%8.98M52.14%-9.77M56.15%-12.03M29.94%-20.42M23.03%-27.43M-150.48%-29.15M-171.45%-35.64M112.33%57.73M316.26%49.88M
-Changes in the fair value of financial assets 208.08%10.56M174.65%8.98M52.14%-9.77M56.15%-12.03M-69.18%-20.42M23.03%-27.43M-121.12%-12.07M-174.86%-35.64M152.08%57.15M372.03%47.61M
-Changes in the fair value of other assets -------------------------3,009.03%-17.08M-----87.01%587K19.86%2.28M
Impairment and provision 68.75%-5.96M-87.12%197K-571.23%-19.08M436.49%1.53M96.24%-2.84M100.58%285K-392.06%-75.64M-297.28%-49.55M177.32%25.9M3,239.50%25.12M
-Impairment of property, machinery and equipment ---------------------------64.13M---41.42M--------
-Other impairment is provision 68.75%-5.96M-87.12%197K-571.23%-19.08M436.49%1.53M75.30%-2.84M103.51%285K-144.44%-11.51M-132.36%-8.13M177.32%25.9M3,239.50%25.12M
Special items of operating profit -69.33%1.58M-69.19%792K-23.50%5.16M-80.15%2.57M179.67%6.75M474.15%12.95M-94.36%-8.47M40.57%-3.46M65.43%-4.36M-10.43%-5.83M
Operating profit 3.23%-46.35M59.00%-9.11M-593.02%-47.9M-151.58%-22.21M105.95%9.72M137.01%43.06M-942.00%-163.23M-297.84%-116.35M148.00%19.39M798.21%58.81M
Financing cost 24.01%-592K44.25%-228K78.77%-779K86.47%-409K52.53%-3.67M26.00%-3.02M5.51%-7.73M-610.26%-4.08M-652.81%-8.18M-103.18%-575K
Earning before tax 3.57%-46.95M58.74%-9.33M-905.18%-48.68M-156.50%-22.62M103.54%6.05M133.25%40.04M-1,626.05%-170.96M-306.80%-120.43M127.01%11.2M996.75%58.24M
Tax 105.05%97K102.98%49K-1,945.19%-1.92M-30.27%-1.64M108.90%104K-534.17%-1.26M95.03%-1.17M-332.61%-199K-3,123.91%-23.53M-127.88%-46K
After-tax profit from continuing operations 7.42%-46.85M61.73%-9.29M-922.76%-50.6M-162.57%-24.26M103.57%6.15M132.14%38.78M-1,296.84%-172.13M-307.31%-120.63M69.72%-12.32M1,019.40%58.19M
Earning after tax 7.42%-46.85M61.73%-9.29M-922.76%-50.6M-162.57%-24.26M103.57%6.15M132.14%38.78M-1,296.84%-172.13M-307.31%-120.63M69.72%-12.32M1,019.40%58.19M
Minority profit 96.00%-170K---160K-222.08%-4.25M----97.30%-1.32M94.81%-1.23M-232.48%-48.81M-853.33%-23.61M-1,363.81%-14.68M-797.46%-2.48M
Profit attributable to shareholders -0.70%-46.68M62.39%-9.13M-720.72%-46.36M-160.66%-24.26M106.06%7.47M141.23%40M-5,327.55%-123.32M-259.92%-97.02M105.94%2.36M1,102.25%60.67M
Basic earnings per share -1.09%-0.009362.50%-0.0018-713.33%-0.0092-160.76%-0.0048106.12%0.0015141.15%0.0079-5,000.00%-0.0245-260.00%-0.0192106.33%0.00051,100.00%0.012
Diluted earnings per share -1.09%-0.009362.50%-0.0018-713.33%-0.0092-160.76%-0.0048106.12%0.0015141.15%0.0079-5,000.00%-0.0245-260.00%-0.0192106.33%0.00051,100.00%0.012
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor ----Zhongshen Zhonghuan (Hong Kong) Fuxin Certified Public Accountants Limited--Kaiyuan Xinde Certified Public Accountants Co., Ltd.--Kaiyuan Xinde Certified Public Accountants Co., Ltd.--Grant Thornton (Hong Kong) Limited--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -